United Therapeutics Corporation
UTHR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,137 | $1,593 | $1,900 | $1,697 |
| Short-Term Investments | $1,631 | $1,456 | $1,421 | $1,570 |
| Receivables | $298 | $379 | $322 | $279 |
| Inventory | $177 | $169 | $165 | $158 |
| Other Curr. Assets | $252 | $230 | $131 | $170 |
| Total Curr. Assets | $3,494 | $3,827 | $3,940 | $3,874 |
| Property Plant & Equip (Net) | $1,556 | $1,362 | $1,303 | $1,222 |
| Goodwill | $0 | $0 | $0 | $32 |
| Intangibles | $117 | $112 | $112 | $80 |
| Long-Term Investments | $1,656 | $1,918 | $1,711 | $1,475 |
| Tax Assets | $355 | $456 | $457 | $458 |
| Other NC Assets | $174 | $233 | $222 | $222 |
| Total NC Assets | $3,857 | $4,081 | $3,804 | $3,490 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,351 | $7,908 | $7,744 | $7,364 |
| Liabilities | – | – | – | – |
| Payables | $468 | $432 | $367 | $6 |
| Short-Term Debt | $0 | $0 | $200 | $300 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $78 | $95 | $155 | $432 |
| Total Curr. Liab. | $546 | $527 | $722 | $738 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $215 | $207 | $215 | $182 |
| Total NC Liab. | $215 | $207 | $215 | $182 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $761 | $734 | $937 | $920 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $8,193 | $7,854 | $7,544 | $7,222 |
| AOCI | $0 | $0 | -$1 | -$3 |
| Other Equity | -$1,603 | -$681 | -$737 | -$776 |
| Total Equity | $6,590 | $7,174 | $6,807 | $6,444 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,351 | $7,908 | $7,744 | $7,364 |
| Net Debt | -$1,137 | -$1,593 | -$1,700 | -$1,397 |